Yves‐Jean Bignon - Concepedia

Author

Yves‐Jean Bignon

Also Known As

Antoine de Pauw, Bignon, Y.J., Bignon, Yves-Jean, Christine Lasset, Daniel Barrowdale, Isabelle Tennevet, Marion Gauthier-Villars, Michel Longy, Nancy Uhrhammer, Olga M Sinilnikova

328

Publications

9.4K

Citations

H-Index

125

Concepts

All Affiliations

Centre Jean Perrin Inserm Université Clermont Auvergne Institut Curie Centre Hospitalier Universitaire de Clermont-Ferrand

About

Yves‐Jean Bignon is an author at Centre Jean Perrin specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	63	2.7K
2	Health Sciences	5	5	297
3	Engineering	4	4	97
4	Natural Sciences	4	4	155
5	Nursing	3	3	114

Yves‐Jean Bignon

126

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Prediction of <i>BRCA1</i> Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype Sunil R. Lakhani, Jorge S. Reis‐Filho, Laura Fulford, Clinical Cancer Research	2005	605
<i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma Nelly Burnichon, Alberto Cascón, Francesca Schiavi, Clinical Cancer Research	2012	321
Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families Sophie Gad, Virginie Caux‐Moncoutier, Sabine Pagès-Berhouet, Oncogene Breast OncologySomatic VariantTumor HeterogeneityMedicineGenetics	2002	188
Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway Stéphane Lafarge, V. Sylvain, Marc Ferrara, Oncogene Signal TransductionSignaling PathwayCell RegulationMedicineCytoskeleton	2001	185
Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. Adam Vardi, Rémy Bosviel, Nadège Rabiau, PubMed	2010	124
High allele loss rates at I7q I2‐q2I in breast and ovarian tumors from <i>BRCAI</i>‐linked families R.S. Cornelis, Susan L. Neuhausen, Ola Johansson, Genes Chromosomes and Cancer	1995	122
Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer Abderrahim El Guerrab, Mahchid Bamdad, Fabrice Kwiatkowski, Oncotarget Breast OncologyMedicineImmunologyKinase InhibitorsPathology	2016	114
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study Aung Ko Win, James G. Dowty, Jeanette C. Reece, The Lancet Oncology Lynch SyndromeRetrospective Cohort StudyCancer RiskCancer EpidemiologyMedicine	2021	112
Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression Marjolaine Ngollo, Marine Daures, Gaëlle Judes, BMC Cancer	2017	109
Spectrum of PTCH1 Mutations in French Patients with Gorlin Syndrome Nathalie Boutet, Yves‐Jean Bignon, Valérie Drouin‐Garraud, Journal of Investigative Dermatology Mendelian DisorderAutoimmune DiseaseGenetic DisorderGeneticsGorlin Syndrome	2003	104

Page 1